Werewolf Therapeutics Inc

NASDAQ:HOWL   3:58:57 PM EDT
17.70
0.00 (0.00%)
Earnings Announcements

Werewolf Therapeutics Reports Quarterly Loss Per Share Of $3.82

Published: 08/12/2021 12:45 GMT
Werewolf Therapeutics Inc (HOWL) - Werewolf Therapeutics - Expects Existing Cash, Cash Equivalents to Enable Funding of Operating Expenses & Capex Requirements Through at Least Q2 of 2023.
Werewolf Therapeutics Inc Qtrly Loss per Share $3.82.
Further Company Coverage: Howlo ((reuters.
Briefs@thomsonreuters.
Com;)).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.42

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.45

More details on our Analysts Page.